Watch LFMD. Know when insiders buy.
One email the day a filing lands. Free.
LFMD
LifeMD, Inc.
3.22
+0.02 +0.62%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
40
WATCH · shorts 40
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $155.2MP/E —DIV YIELD —FCF YIELD -7.12%REV TTM $164.7M +3.8%NET INCOME $201KNET CASH $20.3M52W 2.64 – 6.97SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $47.3M | −3.5% | 88.8% | −$7.1M | −$7.1M | — | -0.16 | −$6.9M | $68K | −$7M | Aug 5 |
| Q1 2026 · Mar 31 | $50.2M | −1.4% | 88.2% | −$8.9M | −$8.9M | — | -0.20 | $445K | $105K | $339K | May 6 |
| Q4 2025 · Dec 31derived | $7.1M | +29.0% | 40.2% | −$6.2M | $20M | — | — | −$3.3M | $155K | −$3.4M | Mar 10 |
| Q3 2025 · Sep 30 | $60.2M | +13.0% | 87.7% | −$2M | −$3.8M | — | — | −$147K | $821K | −$968K | Nov 17 |
| Q2 2025 · Jun 30 | $49M | −3.2% | 86.0% | −$2.3M | −$1.6M | — | -0.05 | $8.6M | $777K | $7.9M | Aug 5 |
| Q1 2025 · Mar 31 | $50.9M | +15.3% | 84.0% | −$1.2M | −$184K | — | -0.02 | $3.1M | $118K | $3M | May 6 |
| Q4 2024 · Dec 31derived | $5.5M | −87.8% | -24.0% | −$6M | −$4.9M | — | -0.14 | $1.1M | $198K | $875K | Mar 10 |
| Q3 2024 · Sep 30 | $53.3M | +38.0% | 90.6% | −$4M | −$4.7M | — | -0.13 | $6.7M | $448K | $6.3M | Nov 17 |
| Q2 2024 · Jun 30 | $50.7M | — | 90.1% | −$6.3M | −$6.9M | — | — | $4.5M | $642K | $3.9M | Aug 5 |
| Q1 2024 · Mar 31 | $44.1M | — | 89.6% | −$6.2M | −$6.8M | — | — | $5.2M | $176K | $5M | May 6 |
| Q4 2023 · Dec 31derived | $44.9M | — | 88.1% | −$2.2M | −$3.7M | — | — | $5.7M | $109K | $5.6M | Mar 11 |
| Q3 2023 · Sep 30 | $38.6M | — | 87.6% | −$4.6M | −$6.1M | — | — | $1.1M | $30K | $1M | Nov 7 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $194.1M | 85.7% | −$7.7M | $14.4M | 7.4% | 0.25 | $8.3M | $1.9M | $6.4M | $270K | $3.1M |
| FY2024 · to Dec 31 | $154.8M | 86.2% | −$20.4M | −$21.4M | -13.8% | -0.60 | $17.5M | $1.5M | $16M | — | $3.1M |
| FY2023 · to Dec 31 | $152.5M | 87.6% | −$14.5M | −$20.6M | -13.5% | — | $8.8M | $204K | $8.6M | — | $3.1M |
| FY2022 · to Dec 31 | $119M | 84.3% | −$43.4M | −$45.5M | -38.3% | — | −$22.9M | $367K | −$23.3M | — | $3.1M |
| FY2021 · to Dec 31 | $92.9M | 80.6% | −$54.3M | −$60.9M | -65.6% | — | −$33.1M | $247K | −$33.3M | — | $871K |
| FY2020 · to Dec 31 | $37.3M | 76.2% | −$57.8M | −$58.6M | -157.3% | — | −$12.1M | — | — | — | — |
Every number comes from LifeMD, Inc.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.